Anixa Biosciences, Inc. (ANIX)
NASDAQ: ANIX · Real-Time Price · USD
2.920
+0.110 (3.91%)
Jan 22, 2025, 3:49 PM EST - Market open
Anixa Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jan '25 Jan 22, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 |
| Market Capitalization | 94 | 113 | 98 | 172 | 143 | 49 | |
| Market Cap Growth | 14.71% | 14.71% | -42.82% | 20.19% | 191.52% | -37.33% | |
| Enterprise Value | 78 | 91 | 72 | 139 | 106 | 40 | |
| Last Close Price | 2.81 | 3.50 | 3.16 | 5.60 | 4.77 | 2.06 | |
| PS Ratio | - | - | 467.53 | - | 279.03 | - | |
| PB Ratio | 4.52 | 5.96 | 4.20 | 6.09 | 4.11 | 5.93 | |
| P/TBV Ratio | 5.63 | 5.63 | 4.03 | 5.91 | 4.03 | 5.59 | |
| EV/Sales Ratio | - | - | 342.38 | - | 206.32 | - | |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Asset Turnover | - | - | 0.01 | - | 0.02 | - | |
| Quick Ratio | 8.04 | 8.04 | 11.89 | 14.60 | 28.13 | 7.62 | |
| Current Ratio | 8.54 | 8.54 | 12.50 | 14.83 | 28.35 | 7.88 | |
| Return on Equity (ROE) | -60.10% | -60.10% | -38.51% | -43.74% | -61.02% | -154.36% | |
| Return on Assets (ROA) | -36.70% | -36.70% | -24.61% | -26.01% | -35.92% | -81.88% | |
| Return on Capital (ROIC) | -40.52% | -40.52% | -26.49% | -27.34% | -37.88% | -98.19% | |
| Earnings Yield | -12.87% | -11.15% | -9.99% | -7.92% | -9.07% | -20.44% | |
| FCF Yield | -7.52% | -6.51% | -6.32% | -3.78% | -3.46% | -12.63% | |
| Buyback Yield / Dilution | -2.96% | -2.96% | -2.00% | -6.28% | -28.57% | -12.33% | |
| Total Shareholder Return | -2.96% | -2.96% | -2.00% | -6.28% | -28.57% | -12.33% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.